| 10x Genomics Inc.. (10/5/20). "Press Release: 10x Genomics Advances into Emerging Field of In Situ Analysis with Two Acquisitions". Pleasanton, CA. |
2020-10-05 |
| 10x Genomics Inc.. (12/10/18). "Press Release: 10x Genomics Acquires Spatial Transcriptomics". Pleasanton, CA. |
2018-12-10 |
| 10x Genomics Inc.. (2/24/21). "Press Release: 10x Genomics Showcases Next Wave of Innovations at First Ever Xperience Event. Acquires Tetramer Shop, Reveals Details on Upcoming Products". Pleasanton, CA. |
2021-02-24 |
| 3B Pharmaceuticals GmbH. (4/24/23). "Press Release: 3B Pharmaceuticals Enters into a Global Exclusive Licensing Agreement for its FAP-Targeting Peptide Technology". Berlin. |
2023-04-24 |
| 3D Systems, Inc.. (2/23/22). "Press Release: 3D Systems to Expand Healthcare Applications Portfolio with Acquisition of Kumovis". Rock Hill, SC. |
2022-02-23 |
| 4BIO Capital (4BIO Ventures Management Ltd.). (9/9/19). "Press Release: 4BIO Capital Raises $50 million in First Close of New Advanced Therapies Fund". London & Boston, MA. |
2019-09-09 |
| 4D Lifetec AG. (7/11/22). "Press Release: 4D Lifetec Announces Successful First closing of CHF 1.9 Million Series B Financing to Launch Its Early Lung Cancer Detection Liquid Biopsy Assay 4D Lifetest Lung Dx in Europe". Cham. |
2022-07-11 |
| 4D Molecular Therapeutics. (4/30/18). "Press Release: 4DMT and Roche Expand Ophthalmology Partnership to Develop and Commercialize Multiple AAV Gene Therapy Products". Emeryville, CA. |
2018-04-30 |
| 4D Pharma plc. (10/8/19). "Press Release: 4D Pharma Collaborates with MSD to Develop Live Biotherapeutics for Vaccines". |
2019-10-08 |
| 4SC AG. (10/7/19). "Press Release: 4SC AG Resolves to Issue New Shares, Santo and ATS Undertake to Subscribe / Buy the New Shares [Not for US, AU, CA, et al.]". Planegg-Martinsried. |
2019-10-07 |
| 4SC AG. (2/6/17). "Press Release: 4SC AG to Present at the 19th Annual BIO CEO & Investor Conference 2017". Planegg-Martinsried. |
2017-02-06 |
| 4SC AG. (3/20/19). "Press Release: 4SC AG Provides Results for Financial Year 2018 and Outlook". Planegg-Martinsried. |
2019-03-20 |
| 4SC AG. (3/21/18). "Press Release: 4SC AG Announces Results for Financial Year 2017". Planegg-Martinsried. |
2018-03-21 |
| 4SC AG. (4/17/18). "Press Release: 4SC at AACR – Broadened Clinical Options for 4SC-202". Planegg-Martinsried. |
2018-04-17 |
| 4SC AG. (8/1/17). "Press Release: 4SC AG Was Granted a Fundamental Composition of Matter Patent for 4SC-208 for the US". Planegg-Martinsried. |
2017-08-01 |
| 4SC AG. (9/20/18). "Press Release: Domatinostat Plus Chemotherapy – Overcoming Drug Resistance". Planegg-Martinsried. |
2018-09-20 |
| 4SC AG. (9/27/23). "Press Release: 4SC Receives Orphan Drug Designation (ODD) for Resminostat (Kinselby) in CTCL from the US FDA". Planegg-Martinsried. |
2023-09-27 |
| 54gene Inc.. (9/16/21). "Press Release: 54gene Closes $25M Series B to Advance Global Drug Discovery Capabilities". Washington, DC. |
2021-09-16 |
| 908 Devices, Inc.. (1/7/22). "Press Release: 908 Devices Announces GSK Purchases Fifth Rebel Cell Culture Media Analyzer". Boston, MA. |
2022-01-07 |
| 908 Devices, Inc.. (6/22/21). "Press Release: 908 Devices Announces New Data Integrations with Key Industry Partners to Accelerate BioProcess Data Insights". Boston, MA. |
2021-06-22 |
| 908 Devices, Inc.. (8/9/22). "Press Release: 908 Devices Acquires Trace Analytics, Enabling On-line Bioanalytics". Boston, MA. |
2022-08-09 |
| Aadi Bioscience, Inc.. (5/8/17). "Press Release: Aadi Bioscience Closes $23 Million in Series A Funding". Pacific Palisades, CA. |
2017-05-08 |
| AAVantgarde Bio S.r.l.. (6/6/23). "Press Release: AAVantgarde Closes €61 Million Series A Financing to Advance Two Therapeutic Programs into the Clinic". Milan. |
2023-06-06 |
| AAVantgarde Bio S.r.l.. (9/8/22). "Press Release: AAVantgarde Bio Appoints Dr. Natalia Misciattelli as Chief Executive Officer". Milan. |
2022-09-08 |
| AB Science S.A.. (3/27/17). "Press Release: AB Science Announces the Success of a Private Placement [Not for US, CA or JP]". Paris. |
2017-03-27 |
| AB Sciex (d/b/a Sciex). (11/09/17). "Press Release: New Method for the Detection of Fipronil Insecticide and Its Associated Metabolites in Eggs and Poultry Launched by Sciex". Warrington. |
2017-11-09 |
| AB Sciex (d/b/a Sciex). (11/1/21). "Press Release: Sciex and Evosep Will Collaborate to Provide Robust, High-throughput Proteomics Workflows". |
2021-11-01 |
| AB Sciex (d/b/a Sciex). (12/18/17). "Press Release: Sciex and NofaLab Collaboration Delivers Robust and Sensitive Method for Detecting Multiple Pesticides in a Single Run". Warrington, UK. |
2017-12-18 |
| AB Sciex (d/b/a Sciex). (2/26/18). "Press Release: Sciex Launches OptiFlow Quant Solution for BioPharma Peptide Quantitation". Framingham, MA. |
2018-02-26 |
| AB Sciex (d/b/a Sciex). (3/22/17). "Press Release: Sciex Presents Novel QTOF Mass Spectrometry System for Simpler and Faster Biotherapeutics Characterisation". Darmstadt. |
2017-03-22 |
| AB Sciex (d/b/a Sciex). (4/10/18). "Press Release: Sciex Launches the Citrine Triple Quad MS/MS Systems in Europe, Bringing Maximal Speed and Sensitivity to Clinical Diagnostics Testing". Darmstadt. |
2018-04-10 |
| AB Sciex (d/b/a Sciex). (5/14/18). "Press Release: Sciex Announces New BioPharmaView Software 3.0 for Streamlining Multiple-Attribute Methods (MAM)". Framingham, MA. |
2018-05-14 |
| AB Sciex (d/b/a Sciex). (6/1/17). "Press Release: Sciex Announces Innovative Solutions for Customer Success Across Markets at ASMS 2017". Framingham, MA. |
2017-06-01 |
| AB Sciex (d/b/a Sciex). (6/1/17). "Press Release: Sciex Launches Its Unrivalled Swath Data Independent Acquisition Technology for Comprehensive Analysis of Food, Forensic and Environmental Samples". Framingham, MA. |
2017-06-01 |
| AB Sciex (d/b/a Sciex). (6/4/18). "Press Release: Sciex OS 1.4 Launches with Next-Generation Algorithms and Complete Data Processing Compatibility across Sciex Mass Spectrometry Platforms". Framingham, MA. |
2018-06-04 |
| AB Sciex (d/b/a Sciex). (7/27/17). "Press Release: Sciex Equipment Is Now Available Through a Wide Range of Flexible Financing Packages via Evosciences". Warrington. |
2017-07-27 |
| AB Sciex (d/b/a Sciex). (9/13/17). "Press Release: Meet Sciex and Learn about Industrialized Biomarker Research Using SWATH Acquisition at HUPO 2017". Framingham, MA. |
2017-09-13 |
| AB Sciex (d/b/a Sciex). (9/15/17). "Press Release: Sciex Announces the Appointment of Inese Lowenstein as President. Former President Jean-Paul Mangeolle to Retire". Framingham, MA. |
2017-09-15 |
| AB Sciex (d/b/a Sciex). (9/5/19). "Press Release: Sciex Launches Partner Portal to Support Customer Needs Worldwide and Extend Network". Framingham, MA. |
2019-09-05 |
| AB Sciex (d/b/a Sciex). (9/8/17). "Press Release: Sciex Launches the Topaz LC-MS/MS System for Clinical Diagnostics in Europe". Warrington, UK. |
2017-09-08 |
| AbbVie Inc.. (10/20/22). "Press Release: AbbVie Acquires DJS Antibodies, Further Strengthening Immunology Pipeline". North Chicago, IL. |
2022-10-20 |
| AbbVie Inc.. (3/1/22). "Press Release: AbbVie Acquires Syndesi Therapeutics, Strengthening Neuroscience Portfolio". North Chicago, IL. |
2022-03-01 |
| AbbVie Inc.. (6/25/19). "Press Release: AbbVie to Acquire Allergan in Transformative Move for Both Companies". |
2019-06-25 |
| Abcam plc. (10/23/20). "Press Release: Abcam Announces Exercise of Over-allotment Option [not for any jurisdiction where a violation of relevant laws]". London. |
2020-10-23 |
| Abcam plc. (10/23/20). "Press Release: Abcam Announces Launch of Offering and Application to List on the Nasdaq Global Market". London. |
2020-10-23 |
| Abcam plc. (10/23/20). "Press Release: Abcam Announces Pricing of Offering on Nasdaq". London. |
2020-10-23 |
| Abcam plc. (5/18/17). "Press Release: Abcam Makes Final Performance-Based AxioMx Milestone Payment". Cambridge. |
2017-05-18 |
| Abcam plc. (6/23/23). "Press Release: Abcam Announces Review of Strategic Alternatives". Cambridge & Waltham, MA. |
2023-06-23 |
| Abcam plc. (8/2/21). "Press Release: Abcam to Acquire BioVision for $340 Million". Cambridge. |
2021-08-02 |
| AbCellera Biologics, Inc.. (11/29/18). "Press Release: AbCellera Collaborates with Autolus on Antibody Discovery Project". Vancouver, BC. |
2018-11-29 |
| AbCellera Biologics, Inc.. (2/14/19). "Press Release: AbCellera Announces Multi-Target Partnership Agreement with a Top 5 Global Pharma". Vancouver, BC. |
2019-02-14 |
| AbCellera Biologics, Inc.. (5/30/18). "Press Release: AbCellera and Harbour Antibodies Announce Technology Co-Offering Agreement for Next-Generation Fully-Human Antibody Discovery". Vancouver, BC, Rotterdam & Cambridge, MA. |
2018-05-30 |
| AbCellera Biologics, Inc.. (9/12/17). "Press Release: AbCellera Launches Antibody Discovery Collaboration with GSK". Vancouver, BC. |
2017-09-12 |
| Aber Instruments. (2/1/21). "Press Release: Aber Instruments Acquires BugLab to Consolidate its World-leading Biomass Monitoring Portfolio". Alexandria, VA. |
2021-02-01 |
| Aber Instruments. (3/22/21). "Press Release: Aber Introduces Futura neotf On-line Single-use Biomass Sensor". Aberystwyth. |
2021-03-22 |
| Abingworth LLP. (10/30/23). "Press Release: Abingworth Raises $356 Million for New Clinical Co-Development Co-Investment Fund (CCD-CIF)". London & New York, NY. |
2023-10-30 |
| Abingworth LLP. (2/3/21). "Press Release: Abingworth Raises $465m for New Life Sciences Fund Abingworth Bioventures 8". London. |
2021-02-03 |
| Abingworth LLP. (5/10/21). "Press Release: Abingworth Raises $582 Million for New Clinical Co-Development Fund – ACCD 2". London. |
2021-05-10 |
| Abingworth LLP. (7/9/18). "Press Release: Abingworth Raises $315m for ABV VII 12th Life Sciences Fund". London. |
2018-07-09 |
| Abingworth LLP. (9/15/21). "Press Release: Abingworth Strengthens Investment Team with New Appointments in the US and UK". London. |
2021-09-15 |
| Abionic S.A.. (9/5/19). "Press Release: Abionic Signs Agreement to Optimize Asthma Management in the U.S. through Innovative Rapid Point-of-Care Tests". Lausanne. |
2019-09-05 |
| Abionyx Pharma S.A.. (8/27/19). "Press Release: Change of Name and Stock Symbol/Mnemonic of Abionyx Pharma Shares (formerly Cerenis Therapeutics) as of August 29, 2019". Toulouse & Lakeland, US. |
2019-08-27 |
| Abionyx Pharma S.A.. (9/9/19). "Press Release: Cyrille Tupin Appointed CEO". Toulouse & Lakeland, US. |
2019-09-09 |
| Abivax S.A.. (1/29/18). "Press Release: Abivax Appoints Carol L. Brosgart, M.D. to Its Board of Directors". Paris. |
2018-01-29 |
| Abivax S.A.. (10/20/23). "Press Release: Abivax Announces the Pricing of Its Initial Public Offering on the Nasdaq Global Market". Paris. |
2023-10-20 |
| Abivax S.A.. (10/24/23). "Press Release: Abivax Announces Closing of its Initial Public Offering on the Nasdaq Global Market". Paris. |
2023-10-24 |
| Abivax S.A.. (12/7/17). "Press Release: Abivax to Present in Plenary Session at the 8th International Conference on HIV Persistence during Therapy". Paris. |
2017-12-07 |
| Abivax S.A.. (3/14/19). "Press Release: Abivax 2018 Financial Results and Operations Update". Paris. |
2019-03-14 |
| Abivax S.A.. (4/9/18). "Press Release: Abivax Strengthens Its Management Team with the Appointment of Alexandra Pearce, Ph.D. as Vice President of Regulatory Affairs". Paris. |
2018-04-09 |
| Abivax S.A.. (6/25/18). "Press Release: Abivax Appoints Ian McGowan as Scientific Advisory Board Chair and Juergen Rockstroh as a New Member". Paris. |
2018-06-25 |
| Abivax S.A.. (7/11/23). "Press Release: Abivax Announces the Appointment of June Lee, M.D. and Troy Ignelzi as Members of the Board of Directors". Paris. |
2023-07-11 |
| Abivax S.A.. (7/23/21). "Press Release: Abivax Announces the Pricing of Its Oversubscribed Capital Increase of EUR 60M and Convertible Bonds of EUR 25M, Totaling EUR 85M New Financing". Paris. |
2021-07-23 |
| Abivax S.A.. (7/25/18). "Press Release: Abivax Secures up to EUR 20m Debt Financing from Kreos Capital". Paris. |
2018-07-25 |
| Abivax S.A.. (8/21/23). "Press Release: Abivax Secures Up to EUR 150M from Two Structured Debt Financing Transactions". Paris. |
2023-08-21 |
| Abivax S.A.. (8/23/23). "Press Release: Abivax Appoints Patrick Malloy as Senior Vice President Investor Relations". Paris. |
2023-08-23 |
| Abivax S.A.. (9/2/22). "Press Release: Abivax Announces Successful Oversubscribed EUR 49.2M Cross-over Financing with Top-tier US and European Biotech Investors [not for US]". Paris. |
2022-09-02 |
| Abivax S.A.. (9/28/17). "Press Release: Abivax’s ABX464 Reduces HIV Reservoir in Blood in Second Phase 2a Clinical Trial". Paris. |
2017-09-28 |
| Abivax S.A.. (9/29/23). "Press Release: Abivax Files Registration Statement for Proposed Initial Public Offering in the United States". Paris. |
2023-09-29 |
| Abivax S.A.. (9/4/18). "Press Release: Abivax Reports Impressive Results in Clinical Phase 2a Trial of ABX464 as an Oral Treatment for Ulcerative Colitis Patients". Paris. |
2018-09-04 |
| ABL Biomanufacutring. (3/27/23). "Press Release: ABL Appoints Stéphanie Colloud as General Manager and Chief Operating Officer to Lead European Activities". Lyon. |
2023-03-27 |
| Ablynx N.V.. (1/24/18). "Press Release: Ablynx Appoints Dr Robert Friesen as Chief Scientific Officer". Ghent. |
2018-01-24 |
| Ablynx N.V.. (1/5/17). "Press Release: Ablynx to Present at the 35th J.P. Morgan Healthcare Conference". Ghent. |
2017-01-05 |
| Ablynx N.V.. (1/8/18). "Press Release: Ablynx Announces Board Changes". Ghent. |
2018-01-08 |
| Ablynx N.V.. (1/8/18). "Press Release: Ablynx Strongly Believes Unsolicited Conditional Proposal from Novo Nordisk Fundamentally Undervalues the Company and Its Future Prospects". Ghent. |
2018-01-08 |
| Ablynx N.V.. (10/16/17). "Press Release: Ablynx Establishes Subsidiary in the USA and Appoints a General Manager". Ghent. |
2017-10-16 |
| Ablynx N.V.. (10/16/17). "Press Release: Publication in Accordance with Article 14 of the Belgian Law of 2 May 2007 Regarding the Publication of Major Sharholdings (the »Transparency Law«) [Consonance Capital Increases Shareholding in Ablynx to 5.04%]". |
2017-10-16 |
| Ablynx N.V.. (10/17/17). "Press Release: Ablynx Announces Launch of Proposed Global Offering". Ghent. |
2017-10-17 |
| Ablynx N.V.. (10/2/17). "Press Release: Ablynx Announces Positive Topline Results from the Phase III HERCULES Study of Caplacizumab for the Treatment of Acquired TTP". Ghent. |
2017-10-02 |
| Ablynx N.V.. (10/2/17). "Press Release: Ablynx Files Registration Statement for a Proposed Global Offering". Ghent. |
2017-10-02 |
| Ablynx N.V.. (10/25/17). "Press Release: Ablynx Prices $200 Million Initial Public Offering in the United States". Ghent. |
2017-10-25 |
| Ablynx N.V.. (10/25/17). "Press Release: Notice in Relation to the Convertible Bonds due May 2020". Ghent. |
2017-10-25 |
| Ablynx N.V.. (10/27/17). "Press Release: Ablynx Announces Full Exercise of Underwriters’ Option to Purchase Additional Shares and End of Stabilization Period". Ghent. |
2017-10-27 |
| Ablynx N.V.. (10/27/17). "Press Release: Ablynx Closes $200 Million Initial Public Offering in the United States". Ghent. |
2017-10-27 |
| Ablynx N.V.. (10/30/17). "Press Release: Ablynx Closes on Underwriters’ Option to Purchase $30 Million of Additional Shares in the U.S. Initial Public Offering". Ghent. |
2017-10-30 |
| Ablynx N.V.. (11/16/17). "Press Release: Ablynx Announces Results for the First Nine Months of 2017 and a Year-to-Date Business Update". Ghent. |
2017-11-16 |
| Ablynx N.V.. (11/21/17). "Press Release: Results from the Phase III HERCULES Study of Caplacizumab for the Treatment of Acquired TTP Selected for Presentation in the Late-breaking Abstracts Session at the 2017 ASH Annual Meeting". Ghent. |
2017-11-21 |
| Ablynx N.V.. (2/7/18). "Press Release: Ablynx Announces Board Changes". Ghent. |
2018-02-07 |
| Ablynx N.V.. (3/26/18). "Press Release: Ablynx Announces Topline Results from the Phase II Study of Vobarilizumab in Patients with Systemic Lupus Erythematosus". Ghent. |
2018-03-26 |
| Ablynx N.V.. (5/16/17). "Press Release: Ablynx to Present at Upcoming USA Investor Conferences". Ghent. |
2017-05-16 |
| Ablynx N.V.. (6/27/17). "Press Release: Ablynx Achieves Second Milestone in Immuno-oncology Collaboration with Merck & Co., Inc., Kenilworth, New Jersey, USA". Ghent. |
2017-06-27 |
![[LSUS] Life-Sciences-USA.com - The Transatlantic Life Sciences Web Portal](/images/basics/lsus-life-sciences-usa-portal-logo.svg){kind=logo}
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20230710-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [MSC] Mass-Spec-Capital.com – The Mass Spectrometry Web Portal 120x600px](/banner/iito-20181119-120-600-msc-mass-spec-capital-com.jpg)
![Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 120x600px](/banner/iito-20150801-120-600-lse-life-sciences-europe-com.jpg)
